These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7818793)

  • 1. Acute inhibitory effect of alcohol on sodium-lithium countertransport.
    Adebayo GI; Gaffney P; Buggy D; Feely J
    Alcohol; 1994; 11(5):367-70. PubMed ID: 7818793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of the temporal effect of alcohol on human erythrocyte sodium-lithium countertransport in relation to membrane cholesterol and phospholipids.
    Adebayo GI; Gaffney P; Feely J
    Alcohol; 1996; 13(6):597-602. PubMed ID: 8949955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catamenial variations in erythrocyte sodium-lithium countertransport and blood pressure.
    Adebayo GI; Hemeryck L; Hall M; Gasparro D; Sinnott M; Feely J
    Clin Sci (Lond); 1997 Jul; 93(1):29-34. PubMed ID: 9279200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma lipids affect maximum velocity not sodium affinity of human sodium-lithium countertransport: distinction from essential hypertension.
    Rutherford PA; Thomas TH; Laker MF; Wilkinson R
    Eur J Clin Invest; 1992 Nov; 22(11):719-24. PubMed ID: 1478240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assay of human erythrocyte sodium-dependent lithium efflux: the importance of timing of blood sampling.
    Adebayo GI; Gaffney P; Sinnott M; Feely J
    Eur J Clin Invest; 1996 Feb; 26(2):131-5. PubMed ID: 8904522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction for the adverse influence of sodium-potassium cotransport on apparent sodium-lithium countertransport activity in human erythrocytes.
    Hardman TC; Morrish Z; Patel M; Chalkley S; Noble MI
    J Pharmacol Toxicol Methods; 2002; 47(1):19-24. PubMed ID: 12387935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulphydryl group control of sodium-lithium countertransport kinetics: a membrane protein control abnormality in essential hypertension.
    Thomas TH; Rutherford PA; West IC; Wilkinson R
    Eur J Clin Invest; 1995 Apr; 25(4):235-40. PubMed ID: 7601199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assay of sodium-lithium countertransport rate by direct measurement of erythrocyte lithium concentrations.
    Siebers RW; Maling TJ
    Clin Chim Acta; 1987 Oct; 168(3):329-36. PubMed ID: 3677431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the erythrocyte sodium-lithium countertransporter: limitations and assumptions of traditional and kinetic methodologies.
    Hardman TC; Thomas T; Lant AF
    J Membr Biol; 1998 Jan; 161(2):197-205. PubMed ID: 9435275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte sodium-lithium countertransport activity and total body insulin-mediated glucose disposal in normoalbuminuric normotensive type 1 (insulin-dependent) diabetic patients.
    Catalano C; Winocour PH; Thomas TH; Walker M; Sum CF; Wilkinson R; Alberti KG
    Diabetologia; 1993 Jan; 36(1):52-6. PubMed ID: 8436253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium-lithium countertransport kinetics in normal and hypertensive human pregnancy.
    Rutherford PA; Thomas TH; MacPhail S; Wilkinson R
    Eur J Clin Invest; 1992 Jan; 22(1):50-4. PubMed ID: 1559543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of erythrocyte lithium-sodium countertransport in patients with affective illness before and during lithium therapy.
    Amsterdam JD; Rybakowski J; Gottlieb J; Frazer A
    J Affect Disord; 1988; 14(1):75-81. PubMed ID: 2828448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium-lithium countertransport kinetics in IgA nephropathy: relation to plasma lipids and renal impairment.
    Ho KK; Thomas TH; Rutherford PA; Wilkinson R
    Nephron; 1995; 69(4):391-6. PubMed ID: 7777102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic behavior of the erythrocyte sodium-lithium countertransporter in nonnephropathic diabetic twins.
    Hardman TC; Dubrey SW; Leslie RD; Lant AF
    Metabolism; 1996 Oct; 45(10):1203-7. PubMed ID: 8843173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies surrounding erythrocyte sodium-lithium countertransport.
    Hardman TC; Lant AF
    J Hypertens; 1996 Jun; 14(6):695-703. PubMed ID: 8793691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of red cell sodium-lithium countertransport measurement--influence of different loading conditions.
    Besch W; Schläger D; Brahm J; Kohnert KD
    Eur J Clin Chem Clin Biochem; 1995 Oct; 33(10):715-9. PubMed ID: 8608193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in erythrocyte sodium-lithium countertransport kinetics in diabetic nephropathy.
    Rutherford PA; Thomas TH; Carr SJ; Taylor R; Wilkinson R
    Clin Sci (Lond); 1992 Mar; 82(3):301-7. PubMed ID: 1312415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of sodium-lithium countertransport activity in patients with uncomplicated type 1 diabetes.
    Rutherford PA; Thomas TH; Carr SJ; Taylor R; Wilkinson R
    Clin Sci (Lond); 1992 Mar; 82(3):291-9. PubMed ID: 1312414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium-lithium countertransport is associated with insulin resistance and urinary albumin excretion in young African-Americans.
    Falkner B; Canessa M; Levison S; Kushner H
    Am J Kidney Dis; 1997 Jan; 29(1):45-53. PubMed ID: 9002529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of sodium-lithium countertransport in normotensive and hypertensive subjects.
    Siebers RW; Maling TJ
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S59-61. PubMed ID: 1708027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.